Glioblastoma Navigator: a Supermind to Fight Glioblastoma all Together
Finally, after several months of development and an unprecedented effort by the volunteers of Glioblastoma.IT ODV, the Glioblastoma Navigator service is finally active, reachable at the web address https://navigator.glioblastomamultiforme.it.
I had promised Emanuele and the other patients by December 2022 but for various reasons, including having underestimated the complexity of the system, we only got there in these days. The important thing is that we did it. Below a video tutorial explaining Glioblastoma Navigator to patients and caregivers. In the coming days, a tutorial will also be created for doctors and specialists.
Please register and use it. Once registered our volunteers will enable your accounts after a quick verification. The success of the system and the possibility of applying advanced statistics and machine learning methods to the data collected depend on the quantity and quality of the information entered. Like all computer systems, Glioblastoma Navigator will also need a run-in period. For requests for help or support on the functioning of Glioblastoma Navigator and suggestions, send an email to firstname.lastname@example.org.
Glioblastoma Navigator is a revolutionary system that leverages information technologies and super connectivity to support glioblastoma patients, their caregivers, physicians and researchers. Thanks to its multiple features, this system offers unprecedented support for the diagnosis, therapy and management of glioblastoma.
For patients, the Glioblastoma Navigator will be an invaluable resource. This system allows you to anonymously enter information about your brain tumor, including characteristics, mutations, therapies followed, and significant events. Thanks to this system, patients can view the history of their tumor and receive suggestions on the nearest specialized centers where to go for individual therapies. Furthermore, patients can access information on active clinical trials and receive personalized advice on the path of care to be evaluated together with the team of doctors who follow them.
For clinicians and researchers, the Glioblastoma Navigator will offer a unique opportunity to collect and analyze data on a scale beyond that available in individual hospitals or specialist centres. This system allows to collect information on a large number of patients with glioblastoma, providing opinions on specific cases and recruiting indirectly patients with suitable characteristics for clinical trials in preparation or in progress. Furthermore, Glioblastoma Navigator will use machine learning to analyze the collected data, detect any correlations and identify promising therapeutic paths. Indeed, Glioblastoma Navigator works like a virtual trial, collecting data from patients and using it to find statistically significant correlations.
In summary, the Glioblastoma Navigator represents a Supermind to fight glioblastoma. Thanks to its ability to involve patients, caregivers, physicians and researchers in a single platform, this system offers unprecedented support for the management of glioblastoma. Glioblastoma Navigator represents an important step in the fight against this devastating disease and could make a major contribution to improving the way it is tackled.